Teva Pharmaceuticals Could Face Billions in Damages From Opioid Lawsuits | Barron's
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - Bloomberg
Teva Pharmaceuticals - Wikipedia
Teva's Adderall Shortage Seen Continuing Into March (TEVA) - Bloomberg
Teva Pharmaceuticals Names Kare Schultz As New CEO | Fortune
CVS, Teva, Allergan and Endo reach $878 million deal with Florida over the opioid crisis - STAT
Future Teva CEO Seeks to 'Formulate Clear Strategy' - YouTube
Teva, Units Held Liable for Fueling N.Y. Opioid Crisis - Bloomberg
With New Teva Deal, Combined NY Settlements With Opioid Makers Top $2 Billion | New York Law Journal
Teva CEO Resigns; Dividend Cut Should Be Next - Bloomberg
Justice Dept reportedly may file charges in its generic-drug probe by year-end
Teva Offers Drugs Valued at $23 Billion to End Opioid Suits - Bloomberg
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - Bloomberg
Teva Agrees to Purchase Rimsa in $2.3 Billion Deal
Teva to lay off 25% of workforce, suspends dividend - BNN Bloomberg
Teva: Reportedly Planning Thousands of Layoffs in the U.S. | Fortune
Teva Hit With New Lawsuit Over Proposed Korlym Drug Copy
Teva Pharmaceutical Will Pay Over $4 Billion in Opioid Settlement - Bloomberg
Teva shares jump in Tel Aviv after report of up to 10,000 job cuts | The Times of Israel
/cloudfront-us-east-2.images.arcpublishing.com/reuters/CCBS56SBRRKUDM7JEVVE3UOQEE.jpg "Teva Pharmaceutical meets forecasts, but 2023 outlook disappoints | Reuters")
Teva Pharmaceutical meets forecasts, but 2023 outlook disappoints | Reuters
Ex-Teva Chairman, Blockchain Investor Accused of Pump-and-Dump Scheme - WSJ
252 Teva Pharmaceuticals Photos and Premium High Res Pictures - Getty Images
Teva: Now What? | Barron's
Teva (TEVA) Agrees to $225 Million Texas Opioid Settlement, AG Says - Bloomberg
